Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Apr 6;22(7):1227–1233. doi: 10.1016/j.bbmt.2016.03.029

Table 2.

Transplant conditioning regimens

High intensity regimens (N=195) Low intensity regimens (N=94)
BU16/CY, no. (%) 90 (46) FLU/TBI200–300, no. (%) 60 (64)
BU16/FLU, no. (%) 27 (14) FLU/TBI400–450, no. (%) 20 (21)
TREO42/FLU/TBI200, no. (%) 31 (16) CY/FLU/TBI200–300, no. (%)  9 (10)
RAB/FLU/TBI200, no. (%)  17 (9) CLOFA/TBI200, no. (%)   3 (3)
TREO42/FLU, no. (%)  12 (6) CY/FLU/TBI400, no. (%)   1 (1)
TBI1200–1320/CY, no. (%)   7 (4) BU8/FLU, no. (%)   1 (1)
RDB/BC8SA/FLU/TBI200, no. (%)   5 (3)
RAB/FLU/TBI200/CY, no. (%)   2 (1)
TBI1320/THIO/FLU, no. (%)   2 (1)
TBI1320/CY/FLU, no. (%)   1 (1)
RAB/FLU/TBI/LI1400, no. (%)   1 (1)

Abbreviations: BU = busulfan; CY = cyclophosphamide; FLU = fludarabine; TREO = treosulfan; TBI = total body irradiation; RAB = radiolabeled antibodies; RDB = radiolabeled dota-biotin; BC8SA = streptavidin-conjugated antiCD45 antibodies; THIO = thiotepa; LI = localized irradiation; CLOFA = clofarabine.